Correlation
The correlation between SUPN and LSCC is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
SUPN vs. LSCC
Compare and contrast key facts about Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SUPN or LSCC.
Performance
SUPN vs. LSCC - Performance Comparison
Loading data...
Key characteristics
SUPN:
0.54
LSCC:
-0.64
SUPN:
0.90
LSCC:
-0.76
SUPN:
1.13
LSCC:
0.91
SUPN:
0.30
LSCC:
-0.69
SUPN:
1.51
LSCC:
-1.40
SUPN:
11.33%
LSCC:
29.98%
SUPN:
35.90%
LSCC:
64.42%
SUPN:
-75.86%
LSCC:
-97.34%
SUPN:
-47.03%
LSCC:
-53.79%
Fundamentals
SUPN:
$1.77B
LSCC:
$6.33B
SUPN:
$1.11
LSCC:
$0.36
SUPN:
28.56
LSCC:
124.83
SUPN:
1.47
LSCC:
3.18
SUPN:
2.66
LSCC:
12.96
SUPN:
1.72
LSCC:
8.72
SUPN:
$668.00M
LSCC:
$488.74M
SUPN:
$531.00M
LSCC:
$316.66M
SUPN:
$166.97M
LSCC:
$66.92M
Returns By Period
In the year-to-date period, SUPN achieves a -12.33% return, which is significantly higher than LSCC's -20.67% return. Over the past 10 years, SUPN has underperformed LSCC with an annualized return of 8.11%, while LSCC has yielded a comparatively higher 21.71% annualized return.
SUPN
-12.33%
-2.31%
-13.32%
16.89%
4.39%
5.62%
8.11%
LSCC
-20.67%
-8.23%
-20.81%
-39.47%
-4.76%
12.56%
21.71%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SUPN vs. LSCC — Risk-Adjusted Performance Rank
SUPN
LSCC
SUPN vs. LSCC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SUPN vs. LSCC - Dividend Comparison
Neither SUPN nor LSCC has paid dividends to shareholders.
Drawdowns
SUPN vs. LSCC - Drawdown Comparison
The maximum SUPN drawdown since its inception was -75.86%, smaller than the maximum LSCC drawdown of -97.34%. Use the drawdown chart below to compare losses from any high point for SUPN and LSCC.
Loading data...
Volatility
SUPN vs. LSCC - Volatility Comparison
The current volatility for Supernus Pharmaceuticals, Inc. (SUPN) is 8.44%, while Lattice Semiconductor Corporation (LSCC) has a volatility of 20.85%. This indicates that SUPN experiences smaller price fluctuations and is considered to be less risky than LSCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SUPN vs. LSCC - Financials Comparison
This section allows you to compare key financial metrics between Supernus Pharmaceuticals, Inc. and Lattice Semiconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SUPN vs. LSCC - Profitability Comparison
SUPN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Supernus Pharmaceuticals, Inc. reported a gross profit of 134.06M and revenue of 149.82M. Therefore, the gross margin over that period was 89.5%.
LSCC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Lattice Semiconductor Corporation reported a gross profit of 81.73M and revenue of 120.15M. Therefore, the gross margin over that period was 68.0%.
SUPN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Supernus Pharmaceuticals, Inc. reported an operating income of -10.26M and revenue of 149.82M, resulting in an operating margin of -6.9%.
LSCC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Lattice Semiconductor Corporation reported an operating income of 6.97M and revenue of 120.15M, resulting in an operating margin of 5.8%.
SUPN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Supernus Pharmaceuticals, Inc. reported a net income of -11.83M and revenue of 149.82M, resulting in a net margin of -7.9%.
LSCC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Lattice Semiconductor Corporation reported a net income of 5.02M and revenue of 120.15M, resulting in a net margin of 4.2%.